Current Pharmacology Reports Q3 Unclaimed
This journal presents incisive reviews by international experts, on all aspects of pharmacology, including drug discovery and development. Coverage spans such key subjects as epigenetics and epigenomics, chemoinformatics, rational drug design and target discovery, drug delivery and biomaterial, pharmacogenomics and molecular targets and biomarkers, chemical/drug/molecular toxicology, absorption, distribution, metabolism and elimination (ADME), pharmacokinetics and pharmacodynamics, modeling & simulation and pharmacometrics, and related topics in disease, including neurology and the central nervous system, cardiovascular disease, metabolic diseases, cancer and others. Presents cutting-edge reviews on subjects pertinent to all aspects of pharmacologyOffers incisive, insightful, and balanced contributions by international leading expertsBenefits a wide readership of scientists and translational investigators in academia and in industry It has an SJR impact factor of 0,441.
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
3190 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
0,441
SJR Impact factor39
H Index33
Total Docs (Last Year)95
Total Docs (3 years)2911
Total Refs259
Total Cites (3 years)94
Citable Docs (3 years)2.46
Cites/Doc (2 years)88.21
Ref/DocOther journals with similar parameters
Cancer genetics Q3
BMC Medical Genomics Q3
Current Stem Cell Reports Q3
Epigenomics Q3
Molecular Genetics and Metabolism Reports Q3
Compare this journals
Comments